07/19/2017 - 4:23pm

The organization has brought onto its board Walgreens VP federal government relations and U.S. public policy Ed Kaleta; Pfizer's regional president North America for rare disease Tolga Tangular; and AstraZeneca’s executive director of access services Blaine Squires. 

07/14/2017 - 11:35am

Tremfya (guselkumab) is the first drug to be approved that selectively blocks a key plaque psoriasis cytokine, the company said.

07/14/2017 - 11:23am

Mike Hotra joins the organization as VP of its public affairs team, and Ken McKay is the advocacy organization’s new VP state government affairs. 

07/12/2017 - 2:55pm
The drug had previously been granted breakthrough therapy designation and accelerated approval.
 
07/07/2017 - 11:54am

Diplomat Specialty Infusion Group’s nutrition division ThriveRx is celebrating 10 years of supporting parenteral and enteral nutrition patients with a website redesign and the rebrand of its Maximize Health program. 

07/06/2017 - 4:05pm
Walmart Specialty Pharmacy provides such services as prior authorization, identifying the lowest possible price for medications and creating a personal care plan for patients. 
06/30/2017 - 1:16pm

Along with the new indication, the Food and Drug Administration DA approved a next-generation sequencing-based test to identify the RAS mutation status of a patient’s tumor, which Amgen said helps identify patients who would benefit from treatment with Vectibix. 

06/29/2017 - 4:57pm

The drug had combined sales of $188 million for the 12 months ended April 2017, the company said.

06/29/2017 - 4:21pm

The agency has outlined its Orphan Drug Modernization plan, which it said is part of a larger effort called the Medical Innovation Development plan modernize and make efficient the FDA’s regulatory tools and policies.